Telmisartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C33H30N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U5SYW473RQ, chemically known as (1,1-biphenyl)-2-carboxylic acid, 4-((1,4-dimethyl-2-propyl(2,6-bi-1h-benzimidazol)-1-yl)methyl)- but generally known as telmisartan, which bears US NIH Compound Identifier 65999. European Medicines Agency schedules Telmisartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10874MIG. The term TELMISARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules telmisartan in its Anatomical Therapeutic Chemical (ATC) Classification. TELMISARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule telmisartan under HS 29339990 and SITC 51577. As of Q4 2014, TELMISARTAN remains the US FDA Preferred Term for this commodity. Telmisartan bears US NLM identifiers UMLS ID C0248719 and NCI Concept Code C47746. SMILES: OC(=O)c1c(c2ccc(Cn3c4c(nc3CCC)c(cc(c4)c3n(c4c(n3)cccc4)C)C)cc2)cccc1.